# ADPT — Adaptive Biotechnologies Corp · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** ADPT  
**Sources:** 22  
**Published:** 2026-10-03  
**Canonical:** https://app.k3vl4r.com/research/deep-research-adpt-adaptive-biotechnologies-corp-catalysts-narrative-r-5859

---

# Adaptive Biotechnologies Corp. (ADPT) — as of ~October 3, 2026

Below is a synthesis of the new sources, drawn on critically and cross-checked against each other. Note where aggregators conflict.

## Market snapshot
ADPT closed at roughly **$28.35** on October 2, 2026, with a market capitalization near **$4.52 billion**, ~159.6M shares outstanding, and a beta near 2.1 [[11]](https://stockanalysis.com/stocks/adpt/forecast/)[[20]](https://finance.yahoo.com/quote/ADPT/)[[22]](https://www.morningstar.com/stocks/xnas/adpt/quote). The stock is near its 52-week high of ~$29.96 (and has roughly doubled the market cap year-over-year, +104%) [[14]](https://www.marketbeat.com/stocks/NASDAQ/ADPT/)[[20]](https://finance.yahoo.com/quote/ADPT/)[[24]](https://stockanalysis.com/stocks/adpt/). It is classified under Healthcare / Diagnostics & Research [[22]](https://www.morningstar.com/stocks/xnas/adpt/quote).

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-adpt-adaptive-biotechnologies-corp-catalysts-narrative-r-5859 (free to sign up)._
